Clinical Trials List
Protocol NumberJ5E-MC-JZXB (GOG-3133; ENGOT-ov97/GINECO-NOGGO/FRAmework-01; APGOT-OV17)
Not yet recruiting
2026-06-01 - 2031-02-28
Phase III
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- YING-CHENG CHIANG Division of Obstetrics & Gynecology
- CHI-HAU CHEN CHI-HAU CHEN Division of Obstetrics & Gynecology
- 施怡倫 Division of Radiology
- 吳晉睿 Division of Obstetrics & Gynecology
- 許恒誠 Division of Obstetrics & Gynecology
- 戴依柔 Division of Obstetrics & Gynecology
- 張文君 Division of Obstetrics & Gynecology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
83-129 participants
-
Global
1080 participants
